Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium

Stem Cells Translational Medicine

Volumn 2, Issue 5, 2013, Pages 384-393

  Buchholz, David E ^a   Pennington, Britney O ^a   Croze, Roxanne H ^a   Hinman, Cassidy R ^a   Coffey, Peter J ^a   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cellular therapy; Differentiation; Embryonic stem cells; Induced pluripotent stem cells; Pluripotent stem cells; Retinal pigmented epithelium

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; MELANOCYTE PROTEIN PMEL 17; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NICOTINAMIDE; OCTAMER TRANSCRIPTION FACTOR 4; PIGMENT EPITHELIUM DERIVED FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; PHAGOCYTOSIS; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD OUTER SEGMENT;

EID: 84877657445     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0163     Document Type: Article

References (39)

1. Khandhadia S, Cherry J, Lotery AJ. Agerelated macular degeneration. Adv Exp Med Biol 2012;724:15-36.
2. Anderson DH, Radeke MJ, Gallo NB et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited. Prog Retin Eye Res 2010;29:95-112.
3. Cruess AF, Berger A, Colleaux K et al. Canadian expert consensus: Optimal treatment of neovascular age-related macular degeneration. Can J Ophthalmol 2012;47:227-235.
4. Rowland TJ, Buchholz DE, Clegg DO. Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol 2012;227:457-466.
5. Chen FK, Uppal GS, MacLaren RE et al. Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular agerelated macular degeneration. Clin Experiment Ophthalmol 2009;37:275-285.
6. Chen FK, Patel PJ, Uppal GS et al. A comparison of macular translocation with patch graft in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:1848-1855.
7. Chen FK, Patel PJ, Uppal GS et al. Long-term outcomes following full macular translocation surgery in neovascular age-related macular degeneration. Br J Ophthalmol 2010;94:1337-1343.
8. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379:713-720.
9. Hu Y, Liu L, Lu B et al. A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res 2012; 48:186-191.
10. Klimanskaya I, Hipp J, Rezai KA et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004;6:217-245.
11. Buchholz DE, Hikita ST, Rowland TJ et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. STEM CELLS 2009;27:2427-2434.
12. Carr AJ, Vugler AA, Hikita ST et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009;4:e8152.
13. Idelson M, Alper R, Obolensky A et al.Directed differentiation of human embryonicstem cells into functional retinal pigment epithelium cells. Cell Stem Cell2009;5:396-408.
14. Zahabi A, Shahbazi E, Ahmadieh H et al. A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012;21:2262-2272.
15. Lamba DA, Karl MO, Ware CB et al. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 2006;103:12769-12774.
16. Martínez-Morales JR, Rodrigo I, Bovolenta P. Eye development: A view from the retina pigmented epithelium. Bioessays 2004;26:766-777.
17. Ahmado A, Carr AJ, Vugler AA et al. Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19. Invest Ophthalmol Vis Sci 2011;52:7148-7159.
18. Woo TH, Patel BK, Cinco M et al. Identification of Leptospira biflexa by real-time homogeneous detection of rapid cycle PCR product. J Microbiol Methods 1999;35:23-30.
19. Radeke MJ, Peterson KE, Johnson LV et al. Disease susceptibility of the human macula: Differential gene transcription in the retinal pigmented epithelium/choroid. Exp Eye Res 2007;85:366-380.
20. Lin H, Clegg DO. Integrin alphavbeta5 participates in the binding of photoreceptorrod outer segments during phagocytosis by cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1998;39:1703-1712
21. Cimadamore F, Curchoe CL, Alderson N etal. Nicotinamide rescues human embryonic stem cell-derived neuroectoderm from parthanatic cell death. STEM CELLS 2009;27:1772-1781.
22. Koh SM. VIP enhances the differentiation of retinal pigment epithelium in culture: From cAMP and pp60(c-src) to melanogenesis and development of fluid transport capacity. Prog Retin Eye Res 2000;19:669-688.
23. Sperger JM, Chen X, Draper JS et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 2003;100:13350-13355.
24. Chapman S, Liu X, Meyers C et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010;120: 2619-2626.
25. Liu X, Ory V, Chapman S et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol 2012;180:599-607.
26. Okumura N, Koizumi N, Ueno M et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol 2012; 181:268-277.
27. Watanabe K, Ueno M, Kamiya D et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007;25:681-686.
28. Ben-David U, Kopper O, Benvenisty N. Expanding the boundaries of embryonic stem cells. Cell Stem Cell 2012;10:666-677.
29. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
30. Meyer JS, Shearer RL, Capowski EE et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009;106:16698-16703.
31. Zuber ME, Gestri G, Viczian AS et al. Specification of the vertebrate eye by a network of eye field transcription factors. Development 2003;130:5155-5167.
32. Vaca P, Berna G, Araujo R et al. Nicotinamide induces differentiation of embryonic stem cells into insulin-secreting cells. Exp Cell Res 2008;314:969-974.
33. Pera EM, Wessely O, Li SY et al. Neural and head induction by insulin-like growth factor signals. Dev Cell 2001;1:655-665.
34. Beattie GM, Lopez AD, Bucay N et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. STEM CELLS 2005;23:489-495.
35. Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. STEM CELLS 2006;24:1476-1486.
36. Vallier L, Alexander M, Pedersen RA. Activin/nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005;118:4495-4509.
37. Eiraku M, Takata N, Ishibashi H et al. Selforganizing optic-cup morphogenesis in threedimensional culture. Nature 2011;472:51-56.
38. Nakano T, Ando S, Takata N et al. Selfformation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012;10:771-785.
39. Ohgushi M, Sasai Y. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states. Trends Cell Biol 2011;21:274-282.